Impact of STAG2 loss on DNA Damage and Immunobiology in Ewing sarcoma |
University of Pittsburgh / Kelly Bailey, MD, PhD |
Innovation Grants |
2022 |
Pennsylvania |
Histone H3.3 Targeted Therapy for Pediatric High-grade Gliomas |
University of California, Davis Medical Center / Paul Knoepfler, PhD |
Innovation Grants |
2015 |
California |
Predicting Outcome and Ameliorating Toxicities of the Immunotherapy of Neuroblastoma |
University of California, San Diego / Alice Yu, MD, PhD |
Innovation Grants |
2011 |
California |
Pediatric Osteosarcoma: Identifying the elusive molecular signature and its relationship to this disease |
St. Jude Children’s Research Hospital / Linda Hendershot, PhD |
Innovation Grants |
2019 |
Tennessee |
Searching for genetic vulnerabilities in osteosarcoma through genome-wide RNAi screening |
Dana-Farber Cancer Institute / Stuart Orkin, MD |
Innovation Grants |
2012 |
Massachusetts |
Predictive Modeling of MDS Disease Progression From Inherited Bone Marrow Failure Syndrome Using Novel Branching Process and Next Generation Sequencing to Improve Patient-Specific Survival |
Cleveland Clinic Foundation / Seth Corey, MD & Marek Kimmel, PhD |
Innovation Grants |
2017 |
Ohio |
HMG-I/Y in pediatric Leukemia and Lymphoma.
|
The Johns Hopkins University School of Medicine / Linda Smith Resar, MD |
Innovation Grants |
2006 |
Maryland |
Role of Protocadherin-9 in Enabling Leukemia Cell Colonization of the CNS |
National Jewish Health / Jordan Jacobelli, PhD |
Innovation Grants |
2017 |
Colorado |
Targeting EZHIP as a therapeutic strategy for infantile ependymomas |
University of Wisconsin - Madison / Peter Lewis, PhD |
Innovation Grants |
2021 |
Wisconsin |
Enhanced Drug Repurposing Screen in DSRCT Enabled by New In Vitro and In Vivo Models Based on CRISPR/Cas9 Genome Engineering |
Memorial Sloan-Kettering Cancer Center / Marc Ladanyi, MD & Maria Jasin, PhD |
Innovation Grants |
2015 |
New York |